GenScript is a world leading technology and service provider of life science R&D and manufacturing, founded in 2002 as one of the first commercialise gene synthesis providers. GenScript provides life sciences services and products to scientists in over 200 countries worldwide, including gene and gene fragments synthesis, DNA/RNA/NGS/qPRC/tRNA, & siRNA oligos, mRNA & circular RNA synthesis, complex recombinant protein and antibody expression and engineering, custom antibody development, as well as a variety of other research-focused catalogue products. GenScript Biotech can also offer custom peptides as well as CRISPR services from research use to cGMP needs.
After two decades of rapid growth, the company has expanded its business in recent years into the fields of immunotherapy and early-phase drug discovery services, CDMO and microbiology.
Driven by the corporate mission of “make people and nature healthier through biotechnology”, GenScript strives to become the most trustworthy biotech company in the world.
With global support from its loyal customers and over 2600 employees located across the globe, GenScript continues to strive towards their vision of being the most reliable biotech company in the world, in service of a better and healthier future.